• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Bret Jackson on Congress' Attempt to Curb Surprise Medical Billing

Video

Attempts to curb surprise medical may still result in patients getting costs elsewhere, said Bret Jackson, president of the Economic Alliance for Michigan.

Attempts to curb surprise medical may still result in patients getting costs elsewhere, said Bret Jackson, president of the Economic Alliance for Michigan.

What is your view on the bill in Congress to reduce healthcare costs and how it approaches surprise medical billing?

So, the debate in Washington is whether or not we’re going to have a Medicare-plus rate to reimburse on surprise bills, or are we going to go into arbitration. And, I think what arbitration does is really codify the practice of surprise billing, which is a way around provider agreements. Instead of patients being able to really see relief, while the bill may relieve the patients upfront, they’re going to get the [charges] in added premiums, increased deductibles, increased co-pays; so, ultimately, a patient is going to pay for a surprise bill.

We would rather see Congress act on policies that allow for a long-term, stable arrangement between providers and insurance companies, rather than have a system where an arbitrator picks one price versus the other.

Related Videos
Phaedra Corso, PhD, associate vice president for research at Indiana University
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Screenshot of Angela Jia, MD, PhD, during a video interview
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Screenshot of Alexander Kutikov, MD, during a video interview
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Screenshot of Mary Dunn, MSN, NP-C, OCN, RN, during a video interview
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Inma Hernandez, PharmD, PhD, professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Screenshot of Joshua Meeks, MD, PhD, during a video interview
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.